Pharmaceutical Packaging Development Matthew S. Thomas Associate - - PowerPoint PPT Presentation
Pharmaceutical Packaging Development Matthew S. Thomas Associate - - PowerPoint PPT Presentation
Pharmaceutical Packaging Development Matthew S. Thomas Associate Senior Consultant Engineer, Packaging Development Eli Lilly and Company October 2 nd , 2010 Technical, Quality and Supervisory Reviews Author Review : I confirm that the information in
Technical, Quality and Supervisory Reviews
Author Review: I confirm that the information in this technical presentation is clearly written, scientifically accurate and does not contain any confidential information. ____________________________________________________________________________________________ Matthew S. Thomas, Assoc. Sr. Consultant Engineer, KY227 Date Technical Review: I have reviewed the information in this technical presentation and confirm it is clearly written and scientifically accurate. ____________________________________________________________________________________________ David Dziennik, Consultant Engineer, KY227 Date Quality Review: I have reviewed the information in this technical presentation and confirm it is clearly written and does not contain any confidential information. ____________________________________________________________________________________________ Harold Lowe, Assoc. Consultant QA Representative, KY114 Date Supervisory Review: I have reviewed the information in this technical presentation and confirm the listed author and reviewers are qualified to complete their activities. ____________________________________________________________________________________________ Randy Thackrey, Director, KY227 Date Matthew S. Thomas, Eli Lilly and Company 2
Pharmaceutical Packaging Development
- Packaging Components and Systems
- Packaging Regulations
- Performance Testing
- Product Protection
- Patient/User Centered Design
3 Matthew S. Thomas, Eli Lilly and Company
Packaging Components and Systems
Primary Packaging Component: packaging component that provides product protection and contains materials of construction that come into contact with a pharmaceutical drug product. Critical Secondary Packaging Component: packaging component that provides product protection but does not contain materials of construction that come into contact with a pharmaceutical drug product.
4 Matthew S. Thomas, Eli Lilly and Company
Packaging Components and Systems
Parenteral Packaging Components for Injection
5 Matthew S. Thomas, Eli Lilly and Company
Packaging Components and Systems
Parenteral Packaging Systems for Injection
6 Matthew S. Thomas, Eli Lilly and Company
Packaging Components and Systems
Dry Solid Oral Packaging Components
Matthew S. Thomas, Eli Lilly and Company 7
Packaging Components and Systems
Matthew S. Thomas, Eli Lilly and Company 8
Dry Solid Oral Packaging Systems
Packaging Regulations
Food Contact
– United States Code of Federal Regulations (CFR) – European Directives
Compendia Standards
– United States Pharmacopeia (USP) – European Pharmacopeia (PhEur) – Japanese Pharmacopeia (JP)
Performance Testing
– American Society for Testing and Materials (ASTM) – International Organization for Standardization (ISO) – International Safe Transit Association (ISTA) – United States and European Pharmacopeia
Matthew S. Thomas, Eli Lilly and Company 9
Stability Testing (Product Protection)
– International Conference on Harmonization (ICH) – World Health Organization (WHO)
Food and Drug Administration (FDA) Guidance
– Container Closure System Suitability
- Protection
- Compatibility
- Safety
- Performance
Poison Prevention Packaging Act
- Child Resistance and Senior Friendly
Matthew S. Thomas, Eli Lilly and Company 10
Packaging Regulations
Performance Testing
Shipping and Distribution (Cold Chain)
Matthew S. Thomas, Eli Lilly and Company 11
Corrugated Shipping Container Gel Pack Insulation (e.g., expanded polystyrene)
Performance Testing
Matthew S. Thomas, Eli Lilly and Company 12
Container Closure Integrity
Sealed Chambers Before Vacuum (1 ATM) Vacuum Applied
Seal Integrity No Seal Integrity
Vacuum / Pressure Decay
Performance Testing
Matthew S. Thomas, Eli Lilly and Company 13
Water Vapor Transmission Rate (WVTR)
= Desiccant Temperature and Relative Humidity (RH) Controlled Chambers
Chamber Condition – 25C/60% RH
Inside Package
0% RH
Inside Package
0% RH
WVTR
mg H2 O/day
Chamber Condition – 25C/60% RH
WVTR
mg H2 O/day
Matthew S. Thomas, Eli Lilly and Company 14
Performance Testing
Water Vapor Transmission Rate (WVTR)
Diffusion Sorption Desorption
Outside Package (high RH) Inside Package (low RH) WVTR
H2 O H2 O
Plastic Wall Cross Section
PET Bottles HDPE Bottles Typical Blister Laminate PVC PVDV
ICH and WHO Stability Conditions
- Zone I and II Countries (Temperate & Subtropical/Mediterranean)
– Real time storage at 25C/60%RH
- Zone III and IV Countries (Hot/Dry & Hot/Humid)
– Real time storage at 30C/65%RH or 30C/75%RH
Matthew S. Thomas, Eli Lilly and Company 15
Product Protection (stability testing)
Matthew S. Thomas, Eli Lilly and Company 16
Patient/User Centered Design
Matthew S. Thomas, Eli Lilly and Company 17
Patient/User Centered Design
Matthew S. Thomas, Eli Lilly and Company 18
Patient/User Centered Design
Matthew S. Thomas, Eli Lilly and Company 19
Patient/User Centered Design
Matthew S. Thomas, Eli Lilly and Company 20